Bispecific Antibody

Chinese Companies Leading the Innovation Frontier of ADCs

by
Chinese Companies Leading the Innovation Frontier of ADCs

â–ŽArmstrong The 2025 American Association for Cancer Research (AACR) Annual Meeting will be held from April 25-30 in Chicago, USA. Recently, the conference abstracts have been released, showcasing a significant presence of Chinese innovations. In the field of ADCs, the majority of reports come from Chinese pharmaceutical companies, with nearly 100 innovative ADCs covering various … Read more

Comprehensive Understanding of ADC Bispecific Antibodies

by
Comprehensive Understanding of ADC Bispecific Antibodies

Antibody-drug conjugates (ADC) have become one of the most sought-after methods for treating cancer patients. Recently, several notable deals have taken place between small biotech companies developing ADCs and large companies looking to enhance their oncology pipelines. The recent Kangfang AK112 incident has brought bispecific antibodies into the spotlight, with some discussing the viability of … Read more